I begin by thanking the Cathaoirleach, Deputies and Senators for inviting the Department to appear before them today. I am principal officer in the Department and am joined by Dr. Damien Barrett, senior superintending veterinary inspector. We are responsible for the development of policy in relation to and the implementation of the bovine TB eradication programme. We welcome the opportunity to appear before the committee to discuss the bovine TB eradication strategy.
The Department is acutely aware of the financial and emotional stress associated with a TB breakdown. It causes significant hardship for farmers and farming families. This Department is committed to the objectives of the bovine TB eradication strategy and programme, which aims to reduce and ultimately eradicate this disease in Ireland. Unfortunately, since we were before the committee last year, the prevailing disease situation has not improved despite the efforts of stakeholders. The importance of Ireland’s TB eradication programme in underpinning farm family income should not be underestimated. As a country that exports 90% of our livestock produce, access to international trade markets is fundamental. It is a requirement of EU trade law to have an eradication programme. This enables Irish farmers to access the EU Single Market for our cattle, including calves, and their meat and milk. This is also a requirement for access to third country markets. Our export markets to third countries have grown substantially in value and volume in the last ten years, and it is notable that in several cases, TB is a significant consideration in the context of trade and certification requirements. A cost benefit analysis report of the TB programme carried out by Grant Thornton in 2021 estimated that in economic terms, 78% of the benefits of the bovine TB eradication programme relate to private goods while 22% accrues to public goods.
TB is a challenging disease to control and eradicate due to several factors. The relative contribution of each of these factors varies from farm to farm. They include movement of cattle with undetected infection; residual infection in cattle previously exposed to TB; the inherent limitations of the tests; a reservoir of disease in a protected species, namely, the badger; and inadequate biosecurity practices on farms. As such, it is important that farmers are empowered to make the best choices for their own circumstances to protect their cattle from TB. It is critical that they are given practical advice based on scientific research about how they can reduce their TB risk, as well as relevant and useful information about their own herds, their own cattle and their own farming practices in order that they can make any management changes which may be necessary if they wish to avoid the costs and stress of a TB breakdown. This includes making informed decisions about the purchase of cattle and maintaining good overall herd health. The advice on how to reduce TB risk in a herd has remained generally consistent over many years and we continue to encourage farmers to act on it utilising a broader range of communication tools. Stakeholder endorsement of this advice, through the TB Forum, is hugely important in encouraging farmers to take active steps to reduce their TB risk.
Vaccinating badgers reduces the transmission of TB within the badger population and thereby reduces transmission to cattle.
This protects cattle and reduces losses to farmers while safeguarding a native protected Irish wild species. Scientific research carried out in Ireland over many years has demonstrated the effectiveness of badger vaccination. We are providing information and advice on the practical steps farmers can take to reduce the risk from badgers by a range of means, including text messages, videos, leaflets and farmer meetings. By combining these practical farmer-led risk reduction actions with the policy of vaccination to prevent breakdowns and targeted licensed badger removal where necessary in response to spillover from badgers to cattle, we can greatly mitigate the risk of TB at the wildlife and cattle interface.
The bovine TB stakeholder forum, established in May 2018, in line with international best practice on the governance of animal health programmes has a mandate to develop evidence-informed policies that can control and ultimately eradicate TB. The Bovine TB Eradication Strategy 2021-2030 was published in January 2021 and identified the key actions necessary to eradicate TB. The key actions in the strategy are preventing spread from herds with a high risk of recurrence; enhanced actions to clear infection from extended breakdown herds; addressing the risk from inconclusive animals; action plans for areas with increased localised TB levels; aligning with changes in the EU animal health law TB regulations; reducing the risk posed by badgers and deer; tailored and simplified communications between the Department and herdowners; clearer messaging of the risks of TB transmission and how to address them; and biosecurity advice delivered to farmers, with a focus on practical, clear and effective actions to reduce risk and incentivise risk-lowering behaviour.
From time to time, a narrative develops that our objective should be to control TB due to the failure thus far to eradicate it. Aside from our EU obligation to have an eradication programme and the importance of this programme to our export partners throughout the world, I wish to be clear that the actions we need to focus on and implement are the same, whether the goal is to control or eradicate this disease.
As of 27 October, 5,906 herds had suffered a TB breakdown in the previous 12 months in comparison with 4,914 in the same period last year. Data analysis suggests the reasons underpinning current levels of TB incidence are the expansion of the dairy herd and the resulting increased levels of intensive cattle farming and increased movement of cattle. These conditions are associated with heightened susceptibility to disease, whether that is TB or any other infectious disease. We have also seen a substantial increase in the number of reactors, with 39,339 being disclosed in the past 12 months in comparison with just over 26,500 in the previous 12 months, an increase of 12,758, or 48%. In addition, almost 9.89 million tests were carried out in the 12 months up to 27 October compared with around 9.66 million tests in the same period in 2023.
In driving strategic change in the bovine TB programme in Ireland, the Minister, Deputy McConalogue, has consistently highlighted the important role of stakeholder collaboration. Reflecting this, implementation of the TB strategy is being facilitated by a governance structure designed to ensure all perspectives are considered. The TB stakeholder forum is supported by three working groups, scientific, finance and implementation, each of which has an independent chair to deliver on its specific terms of reference. The working groups report back to the TB forum as required throughout the year.
In 2023, more than 9.8 million individual animal TB tests were completed in more than 100,000 herds. Delivering the TB programme in any given year represents a massive logistical operation achieved through the co-operation of farmers, private vets and Department officials right across the country. The overall cost to the Exchequer of the TB programme, excluding staff costs, has increased from full-year costs of €57 million in 2023 to €74 million as of the end of October, and it is on track to increase further in 2025. In this time, the primary driver of increased costs has been compensation. For many years, Ireland’s TB programme has been financially supported by the EU. However, EU support for the TB programme has ceased because of funding pressures for other emerging diseases throughout the EU. This funding gap will have to be addressed by the remaining stakeholders and is a potent reminder of the need for collaboration and urgency of action to decrease the disease levels.
The TB strategy sets out how the Department and stakeholders will continue to engage on the issues impacting on TB levels in Ireland, which will involve some difficult choices. By building our policies on a foundation of science and by providing practical science-based advice which farmers can act on to reduce their risks, we can together focus our efforts to protect cattle from infection and farmers from the stress, uncertainty and costs of a breakdown. Most actions set out under the current TB strategy have either been implemented or are advancing well towards implementation. However, we are at a point now where we have to consider whether we are, as a collective, prepared to make the difficult choices that may be required to make a step change. Some of these have been discussed at the TB forum. They include voluntary or mandatory informed purchasing; voluntary or mandatory risk-based trading; incentivising risk-lowering behaviours and disincentivising risk elevating behaviours; reducing spread between areas using contract rearing risk mitigation and restrictions on movements from high to low TB areas; dynamic risk estimation at herd and animal level; supporting quality TB testing using gamma interferon blood testing and spatial tools to identify each group of cattle; and reducing spread from high-risk herds by restricting older breeding cattle and confining TB exposed cattle to controlled finishing units. None of these options are easy for anyone but with stakeholder support, they have the potential to make a real difference.
From the Department’s point of view, we acknowledge the legitimate concerns of those whose businesses and lives are affected by this disease. Equally, we have an obligation to use the best scientific evidence to reduce the risk of infection for herds that are currently free of the disease and to help those with chronic or repeating problems to manage their way out of them. We can only make real progress together and the Department is committed to constructive and collaborative engagement on all of these matters.
We now have the building blocks in place to implement additional measures to the existing TB programme that can lower disease incidence and result in fewer farm families having to endure the challenges associated with a TB restriction. We are committed to constructive engagement with all stakeholders in helping the farming community. I hope that the next time we address the committee on bovine TB, we will be able to outline a positive picture of reducing TB incidence. I welcome any questions from members of the committee.